Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT05855200
Registration number
NCT05855200
Ethics application status
Date submitted
3/05/2023
Date registered
11/05/2023
Date last updated
20/02/2024
Titles & IDs
Public title
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Query!
Scientific title
A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy Versus Standard of Care in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Query!
Secondary ID [1]
0
0
2023-503265-27-00
Query!
Secondary ID [2]
0
0
219606
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
AZUR-2
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Colonic Neoplasms
0
0
Query!
Neoplasms, Colon
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Bowel - Back passage (rectum) or large bowel (colon)
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Other interventions - Dostarlimab
Treatment: Drugs - CAPEOX
Treatment: Drugs - FOLFOX
Experimental: Dostarlimab - Participants will receive Dostarlimab pre and post surgery
Active Comparator: Standard of Care (SOC) - Participants will receive SOC (FOLFOX/CAPEOX) or undergo expectant observation post surgery.
Other interventions: Dostarlimab
Dostarlimab will be administered.
Treatment: Drugs: CAPEOX
CAPEOX will be administered.
Treatment: Drugs: FOLFOX
FOLFOX will be administered.
Query!
Intervention code [1]
0
0
Other interventions
Query!
Intervention code [2]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Event-free Survival (EFS) Assessed by Blinded Independent Central Review (BICR)
Query!
Assessment method [1]
0
0
EFS is defined as the time from randomization to either disease recurrence or death due to any cause or treatment related toxicity that results in the participant not being suitable for surgery
Query!
Timepoint [1]
0
0
Up to approximately 5 years
Query!
Secondary outcome [1]
0
0
Number of Participants with Pathological Response
Query!
Assessment method [1]
0
0
Pathological response will be categorized as a complete pathologic response, major pathologic response, partial pathologic response, or negligible pathologic response.
Query!
Timepoint [1]
0
0
Up to approximately 5 years
Query!
Secondary outcome [2]
0
0
Overall Survival (OS)
Query!
Assessment method [2]
0
0
OS is defined as time from randomization to death from any cause
Query!
Timepoint [2]
0
0
Up to approximately 5 years
Query!
Secondary outcome [3]
0
0
Event-free Survival (EFS) assessed by local assessment
Query!
Assessment method [3]
0
0
EFS is defined as the time from randomization to either disease recurrence or death due to any cause or treatment related toxicity that results in the participant not being suitable for surgery
Query!
Timepoint [3]
0
0
Up to approximately 5 years
Query!
Secondary outcome [4]
0
0
Number of Participants with treatment emergent adverse events (AEs), serious adverse events (SAEs), Immune-related Adverse Event (irAEs), AEs leading to death and AEs leading to discontinuation of study treatment
Query!
Assessment method [4]
0
0
Query!
Timepoint [4]
0
0
Up to approximately 5 years
Query!
Secondary outcome [5]
0
0
Number of Participants with AEs and SAEs by Severity
Query!
Assessment method [5]
0
0
Query!
Timepoint [5]
0
0
Up to approximately 5 years
Query!
Secondary outcome [6]
0
0
Serum Concentration of Dostarlimab
Query!
Assessment method [6]
0
0
Query!
Timepoint [6]
0
0
Predose and End of Infusion (EoI) of Cycle 1 and EoI of Cycle 2 to Cycle 10 (each cycle is of 21 days)
Query!
Secondary outcome [7]
0
0
Serum Concentration of Dostarlimab at End of Infusion (C-EoI)
Query!
Assessment method [7]
0
0
Query!
Timepoint [7]
0
0
End of Infusion (EoI) of Cycle 1 to Cycle 10 (each cycle is of 21 days)
Query!
Secondary outcome [8]
0
0
Serum Predose trough concentration (Ctrough) of Dostarlimab
Query!
Assessment method [8]
0
0
Query!
Timepoint [8]
0
0
Predose of Cycle 1 to Cycle 10 (each cycle is of 21 days)
Query!
Secondary outcome [9]
0
0
Number of Participants with Anti-Drug Antibodies against Dostarlimab
Query!
Assessment method [9]
0
0
Query!
Timepoint [9]
0
0
Up to approximately 5 years
Query!
Eligibility
Key inclusion criteria
- Has untreated pathologically confirmed colon adenocarcinoma
- Has resectable colon adenocarcinoma defined as clinically T4N0 or Stage III
- Has radiologically evaluable disease
- Has a tumor demonstrating the presence of either dMMR status or MSI-H
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Has distant metastatic disease.
- Has received prior medical therapy (chemotherapy, immunotherapy, biologic, or targeted
therapy), radiation therapy or surgery for management of colon cancer
- Has a tumor that, in the investigator's judgment is causing symptomatic bowel
obstruction or otherwise requires urgent/emergent surgery
- Has undergone any major surgical procedure, open biopsy, or experienced significant
traumatic injury within 28 days prior to enrollment
- Has any history of interstitial lung disease or pneumonitis
- Has cirrhosis or current unstable liver or biliary disease per investigator assessment
defined by the presence of ascites, encephalopathy, coagulopathy, hypoalbuminemia,
esophageal/gastric varices, or persistent jaundice
- Has a history of allogenic stem cell transplantation or organ transplantation
- Is receiving any other anticancer or experimental therapy. No other experimental
therapies (including but not limited to chemotherapy, radiation, hormonal treatment,
antibody therapy, immunotherapy, gene therapy, vaccine therapy, or other experimental
drugs) of any kind are permitted while the participant is receiving study intervention
- Is pregnant, breastfeeding, or expecting to conceive children within the projected
duration of the study
- Has a history of severe allergic and/or anaphylactic reactions to chimeric, human or
humanized antibodies, fusion proteins, or known allergies to dostarlimab, or its
excipients, or any components of FOLFOX or CAPEOX
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
2/08/2023
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
25/12/2030
Query!
Actual
Query!
Sample size
Target
711
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,VIC
Query!
Recruitment hospital [1]
0
0
GSK Investigational Site - St Leonards
Query!
Recruitment hospital [2]
0
0
GSK Investigational Site - Waratah
Query!
Recruitment hospital [3]
0
0
GSK Investigational Site - Woolloongabba
Query!
Recruitment hospital [4]
0
0
GSK Investigational Site - Heidelberg
Query!
Recruitment hospital [5]
0
0
GSK Investigational Site - Melbourne
Query!
Recruitment postcode(s) [1]
0
0
2065 - St Leonards
Query!
Recruitment postcode(s) [2]
0
0
2298 - Waratah
Query!
Recruitment postcode(s) [3]
0
0
4102 - Woolloongabba
Query!
Recruitment postcode(s) [4]
0
0
3084 - Heidelberg
Query!
Recruitment postcode(s) [5]
0
0
VIC 3004 - Melbourne
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Arizona
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
California
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Connecticut
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
District of Columbia
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Florida
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Georgia
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Illinois
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Kansas
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Kentucky
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Louisiana
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Maryland
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Michigan
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Minnesota
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Nebraska
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
New Hampshire
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
New York
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
North Carolina
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
Ohio
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
Oklahoma
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
Pennsylvania
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
South Carolina
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
South Dakota
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
Tennessee
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
Texas
Query!
Country [25]
0
0
United States of America
Query!
State/province [25]
0
0
Virginia
Query!
Country [26]
0
0
Argentina
Query!
State/province [26]
0
0
Buenos Aires
Query!
Country [27]
0
0
Argentina
Query!
State/province [27]
0
0
Santa Fe
Query!
Country [28]
0
0
Argentina
Query!
State/province [28]
0
0
Cordoba
Query!
Country [29]
0
0
Belgium
Query!
State/province [29]
0
0
Aalst
Query!
Country [30]
0
0
Belgium
Query!
State/province [30]
0
0
Anderlecht
Query!
Country [31]
0
0
Belgium
Query!
State/province [31]
0
0
Bruxelles
Query!
Country [32]
0
0
Belgium
Query!
State/province [32]
0
0
Edegem
Query!
Country [33]
0
0
Belgium
Query!
State/province [33]
0
0
Gent
Query!
Country [34]
0
0
Belgium
Query!
State/province [34]
0
0
Leuven
Query!
Country [35]
0
0
Belgium
Query!
State/province [35]
0
0
Liège
Query!
Country [36]
0
0
Belgium
Query!
State/province [36]
0
0
Roeselare
Query!
Country [37]
0
0
Brazil
Query!
State/province [37]
0
0
Bahia
Query!
Country [38]
0
0
Brazil
Query!
State/province [38]
0
0
Espírito Santo
Query!
Country [39]
0
0
Brazil
Query!
State/province [39]
0
0
Piauí
Query!
Country [40]
0
0
Brazil
Query!
State/province [40]
0
0
Rio Grande Do Norte
Query!
Country [41]
0
0
Brazil
Query!
State/province [41]
0
0
Rio Grande Do Sul
Query!
Country [42]
0
0
Brazil
Query!
State/province [42]
0
0
Santa Catarina
Query!
Country [43]
0
0
Brazil
Query!
State/province [43]
0
0
São Paulo
Query!
Country [44]
0
0
Canada
Query!
State/province [44]
0
0
Alberta
Query!
Country [45]
0
0
Canada
Query!
State/province [45]
0
0
Ontario
Query!
Country [46]
0
0
Canada
Query!
State/province [46]
0
0
Quebec
Query!
Country [47]
0
0
Canada
Query!
State/province [47]
0
0
Halifax
Query!
Country [48]
0
0
Estonia
Query!
State/province [48]
0
0
Tallinn
Query!
Country [49]
0
0
Estonia
Query!
State/province [49]
0
0
Tartu
Query!
Country [50]
0
0
Finland
Query!
State/province [50]
0
0
Helsinki
Query!
Country [51]
0
0
Finland
Query!
State/province [51]
0
0
Tampere
Query!
Country [52]
0
0
Finland
Query!
State/province [52]
0
0
Turku
Query!
Country [53]
0
0
France
Query!
State/province [53]
0
0
Lyon
Query!
Country [54]
0
0
France
Query!
State/province [54]
0
0
Marseille Cedex 5
Query!
Country [55]
0
0
France
Query!
State/province [55]
0
0
Nantes
Query!
Country [56]
0
0
France
Query!
State/province [56]
0
0
Nice Cedex 2
Query!
Country [57]
0
0
France
Query!
State/province [57]
0
0
Paris
Query!
Country [58]
0
0
France
Query!
State/province [58]
0
0
Pessac cedex
Query!
Country [59]
0
0
France
Query!
State/province [59]
0
0
Rennes Cedex
Query!
Country [60]
0
0
France
Query!
State/province [60]
0
0
Rouen
Query!
Country [61]
0
0
France
Query!
State/province [61]
0
0
Saint-Priest en Jarez
Query!
Country [62]
0
0
France
Query!
State/province [62]
0
0
Suresnes
Query!
Country [63]
0
0
France
Query!
State/province [63]
0
0
Toulouse Cedex 9
Query!
Country [64]
0
0
France
Query!
State/province [64]
0
0
Villejuif Cedex
Query!
Country [65]
0
0
Germany
Query!
State/province [65]
0
0
Baden-Wuerttemberg
Query!
Country [66]
0
0
Germany
Query!
State/province [66]
0
0
Bayern
Query!
Country [67]
0
0
Germany
Query!
State/province [67]
0
0
Hessen
Query!
Country [68]
0
0
Germany
Query!
State/province [68]
0
0
Nordrhein-Westfalen
Query!
Country [69]
0
0
Germany
Query!
State/province [69]
0
0
Sachsen-Anhalt
Query!
Country [70]
0
0
Germany
Query!
State/province [70]
0
0
Sachsen
Query!
Country [71]
0
0
Germany
Query!
State/province [71]
0
0
Schleswig-Holstein
Query!
Country [72]
0
0
Germany
Query!
State/province [72]
0
0
Berlin
Query!
Country [73]
0
0
Greece
Query!
State/province [73]
0
0
Athens
Query!
Country [74]
0
0
Greece
Query!
State/province [74]
0
0
Thessaloniki
Query!
Country [75]
0
0
Hungary
Query!
State/province [75]
0
0
Debrecen
Query!
Country [76]
0
0
Italy
Query!
State/province [76]
0
0
Campania
Query!
Country [77]
0
0
Italy
Query!
State/province [77]
0
0
Emilia Romagna
Query!
Country [78]
0
0
Italy
Query!
State/province [78]
0
0
Lazio
Query!
Country [79]
0
0
Italy
Query!
State/province [79]
0
0
Liguria
Query!
Country [80]
0
0
Italy
Query!
State/province [80]
0
0
Lombardia
Query!
Country [81]
0
0
Italy
Query!
State/province [81]
0
0
Sardegna
Query!
Country [82]
0
0
Italy
Query!
State/province [82]
0
0
Toscana
Query!
Country [83]
0
0
Italy
Query!
State/province [83]
0
0
Veneto
Query!
Country [84]
0
0
Japan
Query!
State/province [84]
0
0
Aichi
Query!
Country [85]
0
0
Japan
Query!
State/province [85]
0
0
Chiba
Query!
Country [86]
0
0
Japan
Query!
State/province [86]
0
0
Fukuoka
Query!
Country [87]
0
0
Japan
Query!
State/province [87]
0
0
Hokkaido
Query!
Country [88]
0
0
Japan
Query!
State/province [88]
0
0
Hyogo
Query!
Country [89]
0
0
Japan
Query!
State/province [89]
0
0
Ibaraki
Query!
Country [90]
0
0
Japan
Query!
State/province [90]
0
0
Kanagawa
Query!
Country [91]
0
0
Japan
Query!
State/province [91]
0
0
Kyoto
Query!
Country [92]
0
0
Japan
Query!
State/province [92]
0
0
Okayama
Query!
Country [93]
0
0
Japan
Query!
State/province [93]
0
0
Osaka
Query!
Country [94]
0
0
Japan
Query!
State/province [94]
0
0
Shizuoka
Query!
Country [95]
0
0
Japan
Query!
State/province [95]
0
0
Tokyo
Query!
Country [96]
0
0
Korea, Republic of
Query!
State/province [96]
0
0
Daegu
Query!
Country [97]
0
0
Korea, Republic of
Query!
State/province [97]
0
0
Seoul
Query!
Country [98]
0
0
Korea, Republic of
Query!
State/province [98]
0
0
Sungnam
Query!
Country [99]
0
0
Mexico
Query!
State/province [99]
0
0
Baja California
Query!
Country [100]
0
0
Mexico
Query!
State/province [100]
0
0
Estado De México
Query!
Country [101]
0
0
Mexico
Query!
State/province [101]
0
0
Jalisco
Query!
Country [102]
0
0
Mexico
Query!
State/province [102]
0
0
Nuevo Leon
Query!
Country [103]
0
0
Mexico
Query!
State/province [103]
0
0
Oaxaca
Query!
Country [104]
0
0
Mexico
Query!
State/province [104]
0
0
Mexico
Query!
Country [105]
0
0
Netherlands
Query!
State/province [105]
0
0
Breda
Query!
Country [106]
0
0
Netherlands
Query!
State/province [106]
0
0
Maastricht
Query!
Country [107]
0
0
Netherlands
Query!
State/province [107]
0
0
Nijmegen
Query!
Country [108]
0
0
Netherlands
Query!
State/province [108]
0
0
Utrecht
Query!
Country [109]
0
0
Norway
Query!
State/province [109]
0
0
Bergen
Query!
Country [110]
0
0
Norway
Query!
State/province [110]
0
0
Drammen
Query!
Country [111]
0
0
Norway
Query!
State/province [111]
0
0
Lørenskog
Query!
Country [112]
0
0
Norway
Query!
State/province [112]
0
0
Oslo
Query!
Country [113]
0
0
Norway
Query!
State/province [113]
0
0
Stavanger
Query!
Country [114]
0
0
Norway
Query!
State/province [114]
0
0
Tromsø
Query!
Country [115]
0
0
Panama
Query!
State/province [115]
0
0
Panama
Query!
Country [116]
0
0
Portugal
Query!
State/province [116]
0
0
Almada
Query!
Country [117]
0
0
Portugal
Query!
State/province [117]
0
0
Coimbra
Query!
Country [118]
0
0
Portugal
Query!
State/province [118]
0
0
Lisboa
Query!
Country [119]
0
0
Spain
Query!
State/province [119]
0
0
Asturias
Query!
Country [120]
0
0
Spain
Query!
State/province [120]
0
0
Madrid
Query!
Country [121]
0
0
Spain
Query!
State/province [121]
0
0
Baracaldo/Vizcaya
Query!
Country [122]
0
0
Spain
Query!
State/province [122]
0
0
Barcelona
Query!
Country [123]
0
0
Spain
Query!
State/province [123]
0
0
Córdoba
Query!
Country [124]
0
0
Spain
Query!
State/province [124]
0
0
Elche
Query!
Country [125]
0
0
Spain
Query!
State/province [125]
0
0
Granada
Query!
Country [126]
0
0
Spain
Query!
State/province [126]
0
0
Jaén
Query!
Country [127]
0
0
Spain
Query!
State/province [127]
0
0
Las Palmas De Gran Canaria
Query!
Country [128]
0
0
Spain
Query!
State/province [128]
0
0
Málaga
Query!
Country [129]
0
0
Spain
Query!
State/province [129]
0
0
Pamplona
Query!
Country [130]
0
0
Spain
Query!
State/province [130]
0
0
San Sebastian
Query!
Country [131]
0
0
Spain
Query!
State/province [131]
0
0
Santander
Query!
Country [132]
0
0
Spain
Query!
State/province [132]
0
0
Sevilla
Query!
Country [133]
0
0
Spain
Query!
State/province [133]
0
0
Valencia
Query!
Country [134]
0
0
Spain
Query!
State/province [134]
0
0
Zaragoza
Query!
Country [135]
0
0
Sweden
Query!
State/province [135]
0
0
Eskilstuna
Query!
Country [136]
0
0
Sweden
Query!
State/province [136]
0
0
Götebrog
Query!
Country [137]
0
0
Sweden
Query!
State/province [137]
0
0
Linköping
Query!
Country [138]
0
0
Sweden
Query!
State/province [138]
0
0
Malmö
Query!
Country [139]
0
0
Sweden
Query!
State/province [139]
0
0
Stockholm
Query!
Country [140]
0
0
Sweden
Query!
State/province [140]
0
0
Uppsala
Query!
Country [141]
0
0
Taiwan
Query!
State/province [141]
0
0
Kaohsiung
Query!
Country [142]
0
0
Taiwan
Query!
State/province [142]
0
0
Tainan
Query!
Country [143]
0
0
Taiwan
Query!
State/province [143]
0
0
Taipei
Query!
Country [144]
0
0
Taiwan
Query!
State/province [144]
0
0
Taoyuan City
Query!
Country [145]
0
0
Turkey
Query!
State/province [145]
0
0
Ankara
Query!
Country [146]
0
0
Turkey
Query!
State/province [146]
0
0
Istanbul
Query!
Country [147]
0
0
United Kingdom
Query!
State/province [147]
0
0
Essex
Query!
Country [148]
0
0
United Kingdom
Query!
State/province [148]
0
0
Gloucestershire
Query!
Country [149]
0
0
United Kingdom
Query!
State/province [149]
0
0
Greater Manchester
Query!
Country [150]
0
0
United Kingdom
Query!
State/province [150]
0
0
Birmingham
Query!
Country [151]
0
0
United Kingdom
Query!
State/province [151]
0
0
Cottingham
Query!
Country [152]
0
0
United Kingdom
Query!
State/province [152]
0
0
Edinburgh
Query!
Country [153]
0
0
United Kingdom
Query!
State/province [153]
0
0
Leeds
Query!
Country [154]
0
0
United Kingdom
Query!
State/province [154]
0
0
London
Query!
Country [155]
0
0
United Kingdom
Query!
State/province [155]
0
0
Sutton
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
GlaxoSmithKline
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab
compared with standard of care (SOC) in participants with untreated T4N0 or Stage III
(resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon
cancer.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT05855200
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
GSK Clinical Trials
Query!
Address
0
0
GlaxoSmithKline
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
US GSK Clinical Trials Call Center
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
877-379-3718
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT05855200
Download to PDF